133 related articles for article (PubMed ID: 1379226)
21. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
[TBL] [Abstract][Full Text] [Related]
22. Capillary electrophoresis of methotrexate polyglutamates and its application in evaluation of gamma-glutamyl hydrolase activity.
Waltham MC; Lin S; Li WW; Göker E; Gritsman H; Tong WP; Bertino JR
J Chromatogr B Biomed Sci Appl; 1997 Feb; 689(2):387-92. PubMed ID: 9080326
[TBL] [Abstract][Full Text] [Related]
23. Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis.
Yamamoto T; Shikano K; Nanki T; Kawai S
Sci Rep; 2016 Oct; 6():35615. PubMed ID: 27752107
[TBL] [Abstract][Full Text] [Related]
24. Fibroblasts from methotrexate-sensitive mice accumulate methotrexate polyglutamates but those from methotrexate-resistant mice do not.
You X; Williams A; Dervieux T; He W; Cronstein BN
Clin Exp Rheumatol; 2013; 31(3):433-5. PubMed ID: 23464989
[TBL] [Abstract][Full Text] [Related]
25. Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates.
Barakat RR; Li WW; Lovelace C; Bertino JR
Gynecol Oncol; 1993 Oct; 51(1):54-60. PubMed ID: 7694891
[TBL] [Abstract][Full Text] [Related]
26. Formation of methotrexate polyglutamates in rat hepatocytes.
Gewirtz DA; White JC; Randolph JK; Goldman ID
Cancer Res; 1979 Aug; 39(8):2914-8. PubMed ID: 455278
[TBL] [Abstract][Full Text] [Related]
27. The kinetics of methotrexate polyglutamation in human breast cancer cells.
Morrison PF; Allegra CJ
Arch Biochem Biophys; 1987 May; 254(2):597-610. PubMed ID: 2437860
[TBL] [Abstract][Full Text] [Related]
28. A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia.
Panetta JC; Yanishevski Y; Pui CH; Sandlund JT; Rubnitz J; Rivera GK; Ribeiro R; Evans WE; Relling MV
Cancer Chemother Pharmacol; 2002 Nov; 50(5):419-28. PubMed ID: 12439601
[TBL] [Abstract][Full Text] [Related]
29. Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo.
Poser RG; Sirotnak FM; Chello PL
Cancer Res; 1981 Nov; 41(11 Pt 1):4441-6. PubMed ID: 6171339
[TBL] [Abstract][Full Text] [Related]
30. Effects of growth rate and methotrexate on folate polyglutamates and folylpolyglutamate hydrolase activity in Krebs ascites cells.
Sur P; Priest DG; Doig MT
Biochem Cell Biol; 1986 Apr; 64(4):363-7. PubMed ID: 3755049
[TBL] [Abstract][Full Text] [Related]
31. Wild-type and drug-resistant Leishmania major hydrolyze methotrexate to N-10-methyl-4-deoxy-4-aminopteroate without accumulation of methotrexate polyglutamates.
Ellenberger TE; Wright JE; Rosowsky A; Beverley SM
J Biol Chem; 1989 Sep; 264(27):15960-6. PubMed ID: 2476435
[TBL] [Abstract][Full Text] [Related]
32. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
Matherly LH; Angeles SM; McGuire JJ
Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
[TBL] [Abstract][Full Text] [Related]
33. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
Rhee MS; Galivan J; Wright JE; Rosowsky A
Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate and methotrexate polyglutamates in human sarcoma metastases after high-dose methotrexate therapy.
Schalhorn A; Sauer H; Wilmanns W; Stupp-Poutot G
Klin Wochenschr; 1983 Nov; 61(21):1089-94. PubMed ID: 6196516
[TBL] [Abstract][Full Text] [Related]
35. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
Jolivet J; Chabner BA
J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of gamma-glutamyl hydrolases in human cells by 2-mercaptomethylglutaric acid.
Whitehead VM; Kalman TI; Vuchich MJ
Biochem Biophys Res Commun; 1987 Apr; 144(1):292-7. PubMed ID: 2437910
[TBL] [Abstract][Full Text] [Related]
37. Studies of formation and efflux of methotrexate polyglutamates with cultured hepatic cells.
Galivan J; Balinska M
Adv Exp Med Biol; 1983; 163():235-46. PubMed ID: 6193687
[TBL] [Abstract][Full Text] [Related]
38. Mechanism-based approaches to inhibition of the synthesis and degradation of folate and antifolate polyglutamates.
Kalman TI
Adv Exp Med Biol; 1993; 338():639-43. PubMed ID: 7508172
[No Abstract] [Full Text] [Related]
39. Synthesis and retention of methotrexate polyglutamates in Ehrlich ascites carcinoma cells.
Balińska M
Drugs Exp Clin Res; 1986; 12(6-7):551-4. PubMed ID: 2427298
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of the accumulation of methotrexate polyglutamate derivatives in Ehrlich ascites tumor cells and isolated rat hepatocytes.
Fry DW; Gewirtz DA; Yalowich JC; Goldman ID
Adv Exp Med Biol; 1983; 163():215-34. PubMed ID: 6193686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
